Literature DB >> 22025235

Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care.

Paul Muntner1, Cara Joyce, Emily B Levitan, Elizabeth Holt, Daichi Shimbo, Larry S Webber, Suzanne Oparil, Richard Re, Marie Krousel-Wood.   

Abstract

OBJECTIVES: Secondary analysis of clinical trial data suggests visit-to-visit variability (VVV) of blood pressure is strongly associated with the incidence of cardiovascular disease. Measurement of blood pressure in usual practice settings may be subject to substantial error, calling into question the value of VVV in real-world settings.
METHODS: We analyzed data on adults of at least 65 years of age with diagnosed hypertension who were taking antihypertensive medication from the Cohort Study of Medication Adherence among Older Adults (n = 772 with 14 or more blood pressure measurements). All blood pressure measurements, taken as part of routine outpatient care over a median of 2.8 years, were abstracted from patients' medical charts.
RESULTS: Using each participant's first seven SBP measurements, the mean intraindividual standard deviation was 13.5 mmHg. The intraclass correlation coefficient for the standard deviation based on the first seven and second seven SBP measurements was 0.28 [95% confidence interval (CI) 0.20-0.34]. Individuals in the highest quintile of standard deviation of SBP based on their first seven measurements were more likely to be in the highest quintile of VVV using their second seven measurements (observed/expected ratio = 1.71, 95% CI 1.29-2.22). Results were similar for other metrics of VVV. The intraclass correlation coefficient was lower for DBP than SBP.
CONCLUSION: These data suggest VVV of SBP measured in a real-world setting is not random. Future studies are needed to assess the prognostic value of VVV of SBP assessed in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025235      PMCID: PMC4867495          DOI: 10.1097/HJH.0b013e32834cf213

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

1.  The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994.

Authors:  Paul Muntner; Daichi Shimbo; Marcello Tonelli; Kristi Reynolds; Donna K Arnett; Suzanne Oparil
Journal:  Hypertension       Date:  2011-01-03       Impact factor: 10.190

2.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

3.  Adjustment for regression dilution in epidemiological regression analyses.

Authors:  M W Knuiman; M L Divitini; J S Buzas; P E Fitzgerald
Journal:  Ann Epidemiol       Date:  1998-01       Impact factor: 3.797

4.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats.

Authors:  Z Z Shan; S M Dai; D F Su
Journal:  J Cardiovasc Pharmacol       Date:  2001-09       Impact factor: 3.105

7.  Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.

Authors:  S C Howard; P M Rothwell
Journal:  Cerebrovasc Dis       Date:  2009-07-24       Impact factor: 2.762

Review 8.  Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults.

Authors:  Marie A Krousel-Wood; Paul Muntner; Tareq Islam; Donald E Morisky; Larry S Webber
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

9.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

Review 10.  Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

Authors:  Alastair J S Webb; Urs Fischer; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

View more
  38 in total

Review 1.  Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).

Authors:  Marissa N Lassere; Kent R Johnson; Michal Schiff; David Rees
Journal:  BMC Med Res Methodol       Date:  2012-03-12       Impact factor: 4.615

2.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

Review 3.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 4.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 5.  Visit-to-Visit Variability of Systolic Blood Pressure and Cardiovascular Disease.

Authors:  Wael F Hussein; Tara I Chang
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

6.  Visit-to-visit blood pressure variability in children and adolescents with renal disease.

Authors:  Hisayo Fujita; Seiji Matsuoka; Midori Awazu
Journal:  Clin Exp Nephrol       Date:  2018-03-14       Impact factor: 2.801

7.  Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study.

Authors:  Elena Myasoedova; Cynthia S Crowson; Abigail B Green; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2014-07-01       Impact factor: 4.666

Review 8.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

9.  Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure.

Authors:  Paul Muntner; Emily B Levitan; Cara Joyce; Elizabeth Holt; Devin Mann; Suzanne Oparil; Marie Krousel-Wood
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-11-28       Impact factor: 3.738

10.  Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.

Authors:  Elvira O Gosmanova; Margit K Mikkelsen; Miklos Z Molnar; Jun L Lu; Lenar T Yessayan; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.